Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA OKs VySpine's ClariVy Cervical IBF System - Orthopedic Design & Technology
OEM News

FDA OKs VySpine’s ClariVy Cervical IBF System

Used in anterior discectomy with fusion (ACDF) procedures.

VySpine has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ClariVy cervical IBF system, which is used in anterior discectomy with fusion (ACDF) procedures.
 
ClariVy Cervical IBF cervical interbody fusion devices are made from either PEEK Optima LT1 or PEEK Optima HA-Enhanced. The former has been the interbody device standard for decades. The latter has embedded hydroxyapatite to create better bony apposition to the implant.
 
“The ClariVy Cervical IBF System is the first in a series of differentiated interbody systems being developed by VySpine,” said Tom McLeer, CEO of VySpine told the press. “Using new materials and creative surgeon input, we are building exceptional quality, flexibility, and pricing into all our products. This is just the next step in a series of exciting, innovative product launches scheduled for 2022.”
 
The implants come in numerous footprints and heights—from 4 to 11mm and with or without locking screws. They’re also available in a range of lordosis. The system features IBF-S implants with self-drilling screws for anchoring directly to the bone.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters